ProCare Health Limited

Health Technology

MedCrypt, Inc. | November 18, 2020

MedCrypt Inc., the main supplier of proactive security answers for the medical care space, today declared Accuray has picked MedCrypt's Software Bill of Materials (SBOM) and Vulnerability Tracking Software, Heimdall, to help upgrade observing the advanced security stance of the organization's arrangement of radiation therapy conveyance, arranging, and information the executives arrangements. Accuray innovations ...

Healthcare Analytics

Globenewswire | May 30, 2023

CareCloud, Inc. a leader in healthcare technology solutions for medical practices and health systems nationwide, announced it has received a favorable review by Forbes. Forbes highlighted CareCloud’s ability to cater to both small and large practices while offering advanced analtics to facilitate data-driven decision making. In an article published in Forbes Advisor, the renowned business publication highlights CareCloud's user-friendly, comprehensive features and its ...

Health Technology

Signify Health | September 26, 2022

Signify Health a leading healthcare platform that leverages advanced analytics, technology, and nationwide healthcare networks to create and power value-based payment programs, has again achieved the National Committee for Quality Assurance certification for the Healthcare Effectiveness Data and Information Set. This is the second year in which the Company has received this certification. NCQA provides accreditations and certifications to evaluate a wide range of organizations acros...

HIT Consultant | February 18, 2020

IBM Watson Health today unveiled its newest cloud-based technology IBM Study Advance at the 11th Annual Summit for Clinical Ops Executives (SCOPE). The data-driven, study design tool, is designed to optimize clinical trial protocol design by merging automated access to real-world patient population data, standardizing protocol template guidance and providing a collaborative workspace designed to facilitate efficiency. On average, a single protocol amendment to a Phase III clinical trial ca...